Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Endocrine 1

Conditions

Prostatic Neoplasms 7Squamous Cell Carcinoma of Head and Neck 4Carcinoma, Non-Small-Cell Lung 4Esophageal Neoplasms 3Stomach Neoplasms 2Oropharyngeal Neoplasms 2Multiple Myeloma 2Mouth Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myeloid, Acute 2Endometrial Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Tongue Neoplasms 1Retinoblastoma 1Recurrence 1Rectal Neoplasms 1Precancerous Conditions 1Pancreatic Neoplasms 1Osteoporosis 1Obesity 1Neoplasms 1Neoplasm Metastasis 1Meningioma 1Melanoma 1Lymphoma, Mantle-Cell 1

Interventions

Metformin 2tislelizumab 1epalrestat 1donafenib 1Observation 1Dexamethasone 1Adrenalectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Diabetes Mellitus × Observation × Clear all
NCT02001051 2018-06-14

Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
4 enrolled 10 charts
EndocrineOther

Adrenal incidentaloma, Adrenal Gland Neoplasms, Cushing Syndrome, Diabetes Mellitus, Hypercholesterolemia, Hypertension, Obesity, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡